Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide

D A Eppstein1, Y V Marsh, B B Schryver

  • 1Cancer and Developmental Biology, Syntex Research, Palo Alto, California 94304.

Insights

Monoclonal antibodies and a synthetic peptide targeting the epidermal growth factor (EGF) receptor inhibit estrogen-stimulated breast cancer cell growth, suggesting autocrine EGF/TGF-alpha signaling. These findings offer insights into growth factor roles in cancer.

Area of Science:

  • * Molecular and Cellular Biology
  • * Cancer Research
  • * Endocrinology

Background:

  • * Estrogen stimulates growth in human mammary adenocarcinoma MCF-7 cells.
  • * Epidermal Growth Factor (EGF) receptor plays a role in cell proliferation.
  • * Autocrine/paracrine signaling via growth factors is implicated in cancer progression.

Purpose of the Study:

  • * To investigate the role of EGF receptor antagonists in inhibiting estrogen-stimulated MCF-7 cell growth.
  • * To explore the mechanism of action of a synthetic TGF-alpha peptide analog.
  • * To determine the involvement of autocrine EGF/TGF-alpha signaling in estrogen-mediated cell proliferation.

Main Methods:

  • * Treatment of MCF-7 cells with monoclonal antibodies against the EGF receptor.
  • * Administration of EGF, TGF-alpha, and a synthetic TGF-alpha peptide analog.
  • * Assessment of cell growth inhibition and specificity using various growth factors (IGF-1, FGF, PDGF).
  • * Investigation of peptide binding and effects on EGF receptor phosphorylation and laminin structure.

Main Results:

  • * Monoclonal antibodies to the EGF receptor inhibited EGF, TGF-alpha, and estrogen-stimulated MCF-7 cell growth.
  • * A synthetic TGF-alpha peptide analog specifically inhibited EGF, TGF-alpha, and estrogen-stimulated growth, but not IGF-1-stimulated growth.
  • * The TGF-alpha peptide affected laminin structure, potentially modulating EGF-mediated cell growth.
  • * The peptide bound to a cell surface component independently of EGF binding and did not directly inhibit EGF receptor phosphorylation.

Conclusions:

  • * Estrogen-stimulated MCF-7 cell growth is significantly mediated by autocrine/paracrine EGF or TGF-alpha-like factors.
  • * The synthetic TGF-alpha peptide acts as a specific growth factor antagonist.
  • * The peptide's effect on laminin may represent a novel mechanism influencing cell growth signaling.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...